Peter Chei-Way Pan, MD

Neuro-Oncology
Accepting New Patients
Profile Headshot

Overview

Peter C. Pan, MD is a board-certified assistant professor of neurology in the Division of Neuro-Oncology. He specializes in the treatment of brain tumors. He studied molecular biology and neurobiology at the University of California Berkeley, medicine at the State University of New York Downstate, and clinical neurology residency at the University of California Davis. He completed subspecialty training in Neuro-Oncology at NewYork-Presbyterian / Columbia University Irving Medical Center and NewYork-Presbyterian Weill Cornell Medical Center.

Areas of Expertise / Conditions Treated

  • Anaplastic Astrocytoma
  • Astrocytoma
  • Brain Metastases
  • Brain Stem Glioma
  • Brain Tumor
  • Central Nervous System Tumors
  • Choroid Plexus Carcinoma
  • Choroid Plexus Papilloma
  • Ependymoma
  • Glioblastoma
  • Hemangioblastoma
  • Leptomeningeal metastases
  • Medulloblastoma
  • Meningioma
  • Neurofibromatosis
  • Oligodendroglioma
  • Second Opinion
  • Spinal Cord Tumor

Academic Appointments

  • Assistant Professor of Neurology at the CUMC

Hospital Affiliations

  • NewYork-Presbyterian / Columbia University Irving Medical Center
  • NewYork-Presbyterian / Weill Cornell Medical Center

Gender

  • Male

Schedule an Appointment

Phone Appointments

New and Existing Patients:

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.

Connect Sign In

Location(s)

710 West 168th Street
New York, NY 10032
Primary
155 White Plains Road
Suite W100
Tarrytown, NY 10591
Phone:

Insurance Accepted

Aetna

  • Aetna Signature Administrators
  • EPO
  • HMO
  • Medicare Managed Care
  • NYP Employee Plan
  • NY Signature
  • POS
  • PPO
  • Student Health

Affinity Health Plan

  • Essential Plan
  • Medicaid Managed Care

AgeWell

  • Medicare Managed Care
  • Special Needs

Amida Care

  • Special Needs

Cigna

  • EPO
  • Great West (National)
  • HMO
  • Medicare Managed Care
  • POS
  • PPO

Emblem/GHI

  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross/Blue Shield

  • EPO
  • HMO
  • Medicare Managed Care
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Leaf (Exchange)
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare (National)

  • MagnaCare

Medicare

  • Railroad
  • Traditional Medicare

Multiplan

  • Multiplan

MVP Health Care

  • Child/Family Health Plus
  • Essential Plan
  • HMO
  • Medicaid Managed Care

Quality Health Management

  • Quality Health Management

RiverSpring

  • Special Needs

UnitedHealthcare

  • Compass (Exchange)
  • Empire Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • Oxford Freedom
  • Oxford HMO
  • Oxford Liberty
  • POS
  • PPO

VNSNY CHOICE

  • Medicare Managed Care
  • SelectHealth
  • Special Needs

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

World Trade Center Health Plan

  • World Trade Center Health Plan

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Education & Training

  • State University of New York Health Science Center at Brooklyn
  • Internship: University of California Davis Medical Center
  • Residency: University of Calfornia Davis Medical Center

Honors & Awards

His work has been presented at national specialty meetings across the country, and he has authored a textbook chapter and review article on clinical management in neuro-oncology.

Research

Dr. Peter Pan's research interests include clinical treatments in neuro-oncology and mechanisms of treatment resistance. He is involved in ongoing research reviewing patterns of distant recurrence in adult gliomas, diagnostic imaging features of primary central nervous system lymphomas, and effects of upfront radiation on outcomes in atypical meningiomas. He is also involved in ongoing collaboration with colleagues at Cornell reviewing quality metrics for clinical trials, and with colleagues from biophysics and computational chemistry at UC Davis researching hot spots in protein-protein binding free energy of the programmed death ligand 1 (PD1-PDL1) immune checkpoint, a frequently-targeted axis in oncology.